References
- Powles T, Bellmunt J, Comperat E, et al. ESMO Guidelines Committee. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(3):244–258.
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
- NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries [Internet]. Lyon, France: International Agency for Research on Cancer; 2021; [December 18, 2021]. Available from: https://nordcan.iarc.fr/en/about.
- Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet. 2016;388(10061):2796–2810.
- Flaig TW, Spiess PE, Agarwal N, et al. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(3):329–354.
- Engholm G, Ferlay J, Christensen N, et al. NORDCAN–a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–736.
- StataCorp. Stata statistical software: Release 17. College Station, TX: StataCorp LLC; 2021.
- Pukkala E, Engholm G, Højsgaard Schmidt LK, et al. Nordic Cancer Registries – an overview of their procedures and data comparability. Acta Oncol. 2018;57(4):440–455.
- Al-Zalabani AH, Stewart KF, Wesselius A, et al. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol. 2016;31(9):811–851.
- Official Statistics of Finland (OSF). Tobacco statistics [e-publication] [Internet]. Helsinki, Finland: National Institute for Health and Welfare (THL). 2021; [cited 27.06.2021]. Available from: http://www.stat.fi/til/tupk/index_en.html.
- Hoffman SJ, Christensen AI. Danskernes rygevaner, Udviklingen fra 1994 til 2017. Statens Institut for Folkesundhed, SDU. 2018. Danish.
- Røyk, alkohol og andre rusmidler [Internet]. 2021; [cited 27.06.2021]. Available from: https://www.ssb.no/helse/helseforhold-og-levevaner/statistikk/royk-alkohol-og-andre-rusmidler. (in Norwegian).
- Folkhälsömyndigheten: Daglig tobaksrökning. [Internet]. 2021; [cited 03.10.2021]. Available from: https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/tolkad-rapportering/folkhalsans-utveckling/resultat/levnadsvanor/tobaksrokning-daglig/. (in Swedish).
- Grimsrud TK, Skaug HK, Larsen IK. Lung cancer—changes in incidence by gender, age and county of residence 1984–2013. Tidsskr nor Laegeforen. 2015;135(20):1844–1849.
- Freedman ND, Silverman DT, Hollenbeck AR, et al. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306(7):737–745.
- Cumberbatch MG, Rota M, Catto JW, et al. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol. 2016;70(3):458–466.
- Andreassen BK, Grimsrud TK, Haug ES. Bladder cancer survival: women better off in the long run. Eur J Cancer. 2018;95:52–58.
- Radkiewicz C, Edgren G, Johansson ALV, et al. Sex differences in urothelial bladder cancer survival. Clin Genitourin Cancer. 2020;18(1):26–34.e6.
- Pasin E, Josephson DY, Mitra AP, et al. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol. 2008;10(1):31–43.
- Sundhedsstyrelsen. Pakkeforløb for kraeft i urinvejene. [Internet]. Sundhedsstyrelsen; 2020; [September 23, 2021]. Available at: https://www.sst.dk/da/Udgivelser/2020/Pakkeforloeb-for-kraeft-i-urinvejene (in Danish).
- Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av blaere- og urotelkreft. Helsedirektoratet; 2021.
- Cancercentrum. Nationellt vårdprogram Cancer i urinblåsa, njurbäcken, urinledare och urinrör. Regionalt cancercentrum syd; 2019.
- Gallagher DJ, Milowsky MI. Bladder cancer. Curr Treat Options Oncol. 2009;10(3–4):205–215.
- Liedberg F, Hagberg O, Aljabery F, et al. Survival after radical cystectomy during holiday periods. Scand J Urol. 2021;55(4):276–280.
- Russell B, Liedberg F, Hagberg O, et al. Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer. Scand J Urol. 2022;56(1):27–33.